For: | Hao WW, Xu F. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling. World J Gastrointest Oncol 2022; 14(7): 1239-1251 [PMID: 36051093 DOI: 10.4251/wjgo.v14.i7.1239] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v14/i7/1239.htm |
Number | Citing Articles |
1 |
Helin Zhang, Xingxing Zhang, Yuelin Zhang, Dali Han, Hualan Ha, Biao Zhang, Panfeng Shang. Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer. Molecular Biotechnology 2024; doi: 10.1007/s12033-024-01149-y
|
2 |
Guohu Han, Shuangshuang Zhou, Junjun Shen, Yuanyuan Yang, Xuyu Bian, Yahu Li, Rui Ling, Rongrui Liang, Min Tao. The role of TMEM26 in disrupting tight junctions and activating NF-κB signaling to promote epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Clinics 2023; 78: 100276 doi: 10.1016/j.clinsp.2023.100276
|
3 |
Yu Mu, Haoxiang Liu, Anni Luo, Qingxiang Zhang. KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway. Thoracic Cancer 2024; 15(33): 2356 doi: 10.1111/1759-7714.15465
|
4 |
Yang He, Pengzhan He, Shimin Lu, Weiguo Dong. KIFC3 Regulates the progression and metastasis of gastric cancer via Notch1 pathway. Digestive and Liver Disease 2023; 55(9): 1270 doi: 10.1016/j.dld.2023.02.014
|
5 |
Shimin Lu, Yinghui Liu, Shan Tian, Yang He, Weiguo Dong. KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway. Experimental Cell Research 2023; 426(1): 113564 doi: 10.1016/j.yexcr.2023.113564
|